loadpatents
Patent applications and USPTO patent grants for Payan; Donald G..The latest application filed is for "compounds and method for treating autoimmune diseases".
Patent | Date |
---|---|
Compounds And Method For Treating Autoimmune Diseases App 20220218705 - Masuda; Esteban ;   et al. | 2022-07-14 |
Compounds and method for treating autoimmune diseases Grant 11,220,496 - Masuda , et al. January 11, 2 | 2022-01-11 |
Axl Inhibitors For Use In Combination Therapy For Preventing, Treating Or Managing Metastatic Cancer App 20210379064 - Hitoshi; Yasumichi ;   et al. | 2021-12-09 |
Method of using a bispecific antibody to conditionally inhibit a receptor signaling complex Grant 11,111,305 - Kinsella , et al. September 7, 2 | 2021-09-07 |
2,4-pyrimidinediamine Compounds And Their Uses App 20210267971 - Singh; Rajinder ;   et al. | 2021-09-02 |
2,4-pyrimidinediamine compounds and their uses Grant 11,007,193 - Singh , et al. May 18, 2 | 2021-05-18 |
2,4-pyrimidinediamine compounds and their uses Grant 10,828,301 - Singh , et al. November 10, 2 | 2020-11-10 |
Protein kinase C inhibitors and uses thereof Grant 10,792,282 - Singh , et al. October 6, 2 | 2020-10-06 |
Compounds And Method For Treating Autoimmune Diseases App 20200087293 - Masuda; Esteban ;   et al. | 2020-03-19 |
2,4-pyrimidinediamine Compounds And Their Uses App 20190358228 - Singh; Rajinder ;   et al. | 2019-11-28 |
Conditionally Effective Bispecific Therapeutics App 20190345252 - KINSELLA; Todd M. ;   et al. | 2019-11-14 |
Axl Inhibitors For Use In Combination Therapy For Preventing, Treating Or Managing Metastatic Cancer App 20190336500 - Hitoshi; Yasumichi ;   et al. | 2019-11-07 |
Compounds and method for treating autoimmune diseases Grant 10,414,758 - Masuda , et al. Sept | 2019-09-17 |
2,4-pyrimidinediamine Compounds And Their Uses App 20190255047 - Singh; Rajinder ;   et al. | 2019-08-22 |
2,4-pyrimidinediamine compounds and their uses Grant 10,369,148 - Singh , et al. | 2019-08-06 |
2,4-pyrimidinediamine compounds and their uses Grant 10,314,840 - Singh , et al. | 2019-06-11 |
Protein Kinase C Inhibitors and Uses Thereof App 20190060310 - Singh; Rajinder ;   et al. | 2019-02-28 |
Protein kinase C inhibitors and uses thereof Grant 10,005,777 - Singh , et al. June 26, 2 | 2018-06-26 |
Compounds And Method For Treating Autoimmune Diseases App 20180141938 - Masuda; Esteban ;   et al. | 2018-05-24 |
Compounds and method for treating autoimmune diseases Grant 9,890,144 - Masuda , et al. February 13, 2 | 2018-02-13 |
Protein Kinase C Inhibitors and Uses Thereof App 20180030050 - Singh; Rajinder ;   et al. | 2018-02-01 |
Protein Kinase C Inhibitors and Uses Thereof App 20170360786 - Singh; Rajinder ;   et al. | 2017-12-21 |
2,4-pyrimidinediamine Compounds And Their Uses App 20170246167 - Singh; Rajinder ;   et al. | 2017-08-31 |
Protein kinase C inhibitors and uses thereof Grant 9,682,976 - Singh , et al. June 20, 2 | 2017-06-20 |
2,4-pyrimidinediamine Compounds And Their Uses App 20170081290 - Singh; Rajinder ;   et al. | 2017-03-23 |
2,4-pyrimidinediamine compounds and their uses Grant 9,586,908 - Singh , et al. March 7, 2 | 2017-03-07 |
Axl Inhibitors For Use In Combination Therapy For Preventing, Treating Or Managing Metastatic Cancer App 20170042891 - Hitoshi; Yasumichi ;   et al. | 2017-02-16 |
Protein kinase C inhibitors and uses thereof Grant 9,566,278 - Singh , et al. February 14, 2 | 2017-02-14 |
2,4-pyrimidinediamine compounds and their uses Grant 9,540,334 - Singh , et al. January 10, 2 | 2017-01-10 |
2,4-pyrimidinediamine compounds and their uses Grant 9,499,493 - Singh , et al. November 22, 2 | 2016-11-22 |
Protein Kinase C Inhibitors and Uses Thereof App 20160257681 - Singh; Rajinder ;   et al. | 2016-09-08 |
Synthesis of polycyclic alkaloids Grant 9,353,112 - Goff , et al. May 31, 2 | 2016-05-31 |
Protein kinase C inhibitors and uses thereof Grant 9,321,763 - Singh , et al. April 26, 2 | 2016-04-26 |
Protein Kinase C Inhibitors and Uses Thereof App 20160058760 - Singh; Rajinder ;   et al. | 2016-03-03 |
2,4-pyrimidinediamine Compounds And Their Uses App 20160009661 - Singh; Rajinder ;   et al. | 2016-01-14 |
2,4-pyrimidinediamine Compounds And Their Uses App 20160009660 - Singh; Rajinder ;   et al. | 2016-01-14 |
2,4-pyrimidinediamine Compounds And Their Uses App 20150329532 - Singh; Rajinder ;   et al. | 2015-11-19 |
Compounds And Method For Treating Autoimmune Diseases App 20150313899 - Masuda; Esteban ;   et al. | 2015-11-05 |
Protein kinase C inhibitors and uses thereof Grant 9,169,249 - Singh , et al. October 27, 2 | 2015-10-27 |
2,4-Pyrimidinediamine compounds and their uses Grant 9,162,989 - Singh , et al. October 20, 2 | 2015-10-20 |
2,4-pyridinediamine compounds and their uses Grant 9,133,133 - Singh , et al. September 15, 2 | 2015-09-15 |
2,4-pyrimidinediamine Compounds And Their Uses App 20150158823 - Singh; Rajinder ;   et al. | 2015-06-11 |
2,4-pyrimidinediamine compounds and their uses Grant 9,040,550 - Singh , et al. May 26, 2 | 2015-05-26 |
Synthesis of polycyclic alkaloids Grant 8,927,564 - Goff , et al. January 6, 2 | 2015-01-06 |
2,4-pyrimidinediamine Compounds And Their Uses App 20140330007 - Singh; Rajinder ;   et al. | 2014-11-06 |
2,4-pyridinediamine Compounds And Their Uses App 20140303154 - Singh; Rajinder ;   et al. | 2014-10-09 |
2,4-pyrimidinediamine compounds and their uses Grant 8,853,397 - Singh , et al. October 7, 2 | 2014-10-07 |
Protein Kinase C Inhibitors and Uses Thereof App 20140275055 - Singh; Rajinder ;   et al. | 2014-09-18 |
2,4-pyrimidinediamine compounds and their uses Grant 8,822,685 - Singh , et al. September 2, 2 | 2014-09-02 |
Compounds And Method For Treating Autoimmune Diseases App 20140213555 - Masuda; Esteban ;   et al. | 2014-07-31 |
Axl Inhibitors For Use In Combination Therapy For Preventing, Treating Or Managing Metastatic Cancer App 20130338161 - Hitoshi; Yasumichi ;   et al. | 2013-12-19 |
Protein Kinase C Inhibitors and Uses Thereof App 20130331374 - Singh; Rajinder ;   et al. | 2013-12-12 |
2,4-pyrimidinediamine Compounds And Their Uses App 20130324524 - Singh; Rajinder ;   et al. | 2013-12-05 |
Method Of Treating Muscular Degradation App 20130310340 - Payan; Donald G. ;   et al. | 2013-11-21 |
Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds Grant 8,575,165 - Gururaja , et al. November 5, 2 | 2013-11-05 |
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds Grant 8,557,806 - Singh , et al. October 15, 2 | 2013-10-15 |
Model for Muscle Atrophy App 20130269046 - Kinsella; Todd M. ;   et al. | 2013-10-10 |
Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer Grant 8,546,433 - Hitoshi , et al. October 1, 2 | 2013-10-01 |
Synthesis Of Polycyclic Alkaloids App 20130237524 - Goff; Dane ;   et al. | 2013-09-12 |
Methods of treating cell proliferative disorders Grant 8,481,521 - Masuda , et al. July 9, 2 | 2013-07-09 |
2,4-pyrimidinediamine Compounds And Their Uses App 20130150349 - Singh; Rajinder ;   et al. | 2013-06-13 |
2,4-pyrimidinediamine compounds for treatment of inflammatory disorders Grant 8,334,297 - Li , et al. December 18, 2 | 2012-12-18 |
2,4-pyrimidinediamine compounds and their uses Grant 8,334,296 - Singh , et al. December 18, 2 | 2012-12-18 |
Methods of Treating Cell Proliferative Disorders App 20120245127 - Masuda; Esteban ;   et al. | 2012-09-27 |
Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds App 20120230984 - Singh; Rajinder ;   et al. | 2012-09-13 |
Methods of treating cell proliferative disorders Grant 8,227,455 - Masuda , et al. July 24, 2 | 2012-07-24 |
2,4-pyrimidinediamine compounds and their uses Grant 8,188,276 - Singh , et al. May 29, 2 | 2012-05-29 |
2,4-pyrimidinediamine compounds and their uses Grant 8,148,525 - Singh , et al. April 3, 2 | 2012-04-03 |
shRNA library Grant 7,863,222 - Payan , et al. January 4, 2 | 2011-01-04 |
N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines Grant 7,825,116 - Singh , et al. November 2, 2 | 2010-11-02 |
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds Grant 7,812,029 - Singh , et al. October 12, 2 | 2010-10-12 |
Axl Inhibitors For Use In Combination Therapy For Preventing, Treating Or Managing Metastatic Cancer App 20100196511 - Hitoshi; Yasumichi ;   et al. | 2010-08-05 |
Methods For Treating Inflammatory Disorders Using 2,4-pyrimidinediamine Compounds App 20100179165 - Gururaja; Tarikere ;   et al. | 2010-07-15 |
2,4-pyrimidinediamine Compounds For Treatment Of Inflammatory Disorders App 20100179164 - Li; Hui ;   et al. | 2010-07-15 |
Methods and compositions for identifying peptide modulators of cell surface receptors Grant 7,745,196 - Wong , et al. June 29, 2 | 2010-06-29 |
Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds App 20100125069 - Singh; Rajinder ;   et al. | 2010-05-20 |
Compositions And Methods For Treating Inflammatory Disorders App 20100041678 - Payan; Donald G. | 2010-02-18 |
shRNA library App 20100029505 - Payan; Donald G. ;   et al. | 2010-02-04 |
Intermediates for making 2,4-pyrimidinediamine compounds Grant 7,655,797 - Singh , et al. February 2, 2 | 2010-02-02 |
Compositions And Methods For Treating Inflammatory Disorders App 20090306028 - Payan; Donald G. | 2009-12-10 |
2,4-pyrimidinediamine Compounds And Their Uses App 20090171085 - Singh; Rajinder ;   et al. | 2009-07-02 |
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds Grant 7,517,886 - Singh , et al. April 14, 2 | 2009-04-14 |
Benzothniazole compositions and their use as ubiquition ligation inhibitors App 20080039629 - Ramesh; Usha V. ;   et al. | 2008-02-14 |
Methods Of Treating Or Preventing Autoimmune Diseases With 2,4-pyrimidinediamine Compounds App 20070299095 - Singh; Rajinder ;   et al. | 2007-12-27 |
Multidimensional biodata integration and relationship inference Grant 7,243,112 - Qu , et al. July 10, 2 | 2007-07-10 |
Compositions and Methods For Treating Inflammatory Disorders App 20070117775 - Payan; Donald G. | 2007-05-24 |
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds App 20070060603 - Singh; Rajinder ;   et al. | 2007-03-15 |
Rhodanine derivatives and pharmaceutical compositions containing them App 20060276520 - Singh; Rajinder ;   et al. | 2006-12-07 |
Methods of treating cell proliferative disorders App 20060276459 - Masuda; Esteban ;   et al. | 2006-12-07 |
Methods and compositions for the identification of anti-poxvirus agents Grant 7,132,234 - Lu , et al. November 7, 2 | 2006-11-07 |
Heterocyclic inhibitors of IRES-mediated translation and methods of use thereof App 20060116316 - Kinsella; Todd M. ;   et al. | 2006-06-01 |
Methods and compositions for the identification of anti-poxvirus agents App 20050180994 - Lu, Henry H. ;   et al. | 2005-08-18 |
Benzothiazole compositions and their use as ubiquitin ligase inhibitors App 20050130974 - Ramesh, Usha V. ;   et al. | 2005-06-16 |
Inhibition of retroviral replication through modulation of the host cell ubiquitylation App 20050112562 - Payan, Donald G. ;   et al. | 2005-05-26 |
Multidimensional biodata integration and relationship inference App 20040162852 - Qu, Kunbin ;   et al. | 2004-08-19 |
SEC | 0001190275 | PAYAN DONALD G |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.